Ex) Article Title, Author, Keywords
PDF
Standard view
Export citation
Share 
pISSN 1598-298X
eISSN 2384-0749
Ex) Article Title, Author, Keywords
J Vet Clin 2015; 32(6): 486-490
https://doi.org/10.17555/jvc.2015.12.32.6.486
Published online December 31, 2015
Chang-ho Shin, Tae-sung Hwang, Young-min Yoon, Dong-in Jung, Seong-chan Yeon, Hee-chun Lee
Copyright © The Korean Society of Veterinary Clinics.
Two-demensional echocardiography is routinely used for evaluation of cardiac function. Visualization of the endocardial border is essential for the assessment of global and regional left ventricular with cardiac disease. SonoVueTM is a microbubble contrast agent that consists of sulfur hexafluoride-filled microbubbles in a phospholipid shell. There were many studies about contrast echocardiographic examination using SonoVueTM contrast agent, and various doses of SonoVueTM were used. To our knowledge, in published veterinary medicine, there was not reported for diagnostic efficient dose of SonoVueTM to evaluate contrast enhanced left ventricular endocardial border delineation (LVEBD). The purpose of this study is to compare the visualization time of LVEBD and find efficient dose of SonoVueTM for using various doses in dogs. Ten healthy Beagles were recruited to the study. Three different doses (0.03 ml/kg, 0.05 ml/ kg and 0.1 ml/kg) of SonoVueTM were injected. Endocardial segments were assigned based on previously established methodology, where by the four-chamber views of the LV were divided into 6 segments. In this study, Contrast enhancement of the LVEBD after each injection was evaluated visually at the time point of overall contrast enhancement (Segmental scoring 5+) in the LV by three investigators in a blind manner. Statistical analysis was performed with SPSS version 14.0. All data were analyzed using one-way ANOVA, the multiple comparison Scheffe test. When data for the three offsite readers were combined, mean durations of useful contrast were 3.54 (± 2.14), 6.15 (± 2.61), and 24.39 (± 11.10) seconds for the 0.03 ml/kg, 0.05 ml/kg, and 0.1 ml/kg SonoVueTM doses, respectively. After injection of contrast agent, there were no significant change in side effects such as urticaria, angioedema, hypersensitivity reactions, and digestive system disorders. This study suggests that efficient dose of SonoVueTM contrast agent for improvement of the left ventricle visualization is 0.1 ml/kg. The duration of useful enhancement of LVEBD and the reproducibility were also the highest at the 0.1 ml/kg dosage.
Keywords: Ultrasound Contrast Agent, Left Ventricle Visualization, Dog
J Vet Clin 2015; 32(6): 486-490
Published online December 31, 2015 https://doi.org/10.17555/jvc.2015.12.32.6.486
Copyright © The Korean Society of Veterinary Clinics.
Chang-ho Shin, Tae-sung Hwang, Young-min Yoon, Dong-in Jung, Seong-chan Yeon, Hee-chun Lee
Institute of Animal Medicine, College of Veterinary Medicine, Gyeongsang National University, Jinju 660-701, Korea
Two-demensional echocardiography is routinely used for evaluation of cardiac function. Visualization of the endocardial border is essential for the assessment of global and regional left ventricular with cardiac disease. SonoVueTM is a microbubble contrast agent that consists of sulfur hexafluoride-filled microbubbles in a phospholipid shell. There were many studies about contrast echocardiographic examination using SonoVueTM contrast agent, and various doses of SonoVueTM were used. To our knowledge, in published veterinary medicine, there was not reported for diagnostic efficient dose of SonoVueTM to evaluate contrast enhanced left ventricular endocardial border delineation (LVEBD). The purpose of this study is to compare the visualization time of LVEBD and find efficient dose of SonoVueTM for using various doses in dogs. Ten healthy Beagles were recruited to the study. Three different doses (0.03 ml/kg, 0.05 ml/ kg and 0.1 ml/kg) of SonoVueTM were injected. Endocardial segments were assigned based on previously established methodology, where by the four-chamber views of the LV were divided into 6 segments. In this study, Contrast enhancement of the LVEBD after each injection was evaluated visually at the time point of overall contrast enhancement (Segmental scoring 5+) in the LV by three investigators in a blind manner. Statistical analysis was performed with SPSS version 14.0. All data were analyzed using one-way ANOVA, the multiple comparison Scheffe test. When data for the three offsite readers were combined, mean durations of useful contrast were 3.54 (± 2.14), 6.15 (± 2.61), and 24.39 (± 11.10) seconds for the 0.03 ml/kg, 0.05 ml/kg, and 0.1 ml/kg SonoVueTM doses, respectively. After injection of contrast agent, there were no significant change in side effects such as urticaria, angioedema, hypersensitivity reactions, and digestive system disorders. This study suggests that efficient dose of SonoVueTM contrast agent for improvement of the left ventricle visualization is 0.1 ml/kg. The duration of useful enhancement of LVEBD and the reproducibility were also the highest at the 0.1 ml/kg dosage.
Keywords: Ultrasound Contrast Agent, Left Ventricle Visualization, Dog
